← Open Payments lookup

EJEMENARE DAUDU: Open Payments

NPI 1245905058 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$451 in 14 payments from 5 companies in 2025. Trend: 2023 $356 · 2024 $111 · 2025 $451

Food & beverage: $451
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$189
Alkermes, Inc.1$86
Neurocrine BioSciences, Inc.3$79
Otsuka America Pharmaceutical, Inc.4$72
E.R. Squibb & Sons, L.L.C.1$25

Products named: UZEDY, LYBALVI, INGREZZA, ABILIFY ASIMTUFII, COBENFY, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.